Crewe Advisors LLC Laboratory Corp Of America Holdings Transaction History

Crewe Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$209.01 - $232.56 $9,196 - $10,232	44 New	44 $9,000
Q4 2022 Feb 07, 2023	SELL	$203.72 - $248.97 $1,629 - $1,991	-8 Reduced 72.73%	3 $0
Q3 2022 Nov 14, 2022	BUY	$204.81 - $262.19 $2,252 - $2,884	11 New	11 $2,000
Q3 2021 Oct 29, 2021	SELL	$274.82 - $308.34 $8,244 - $9,250	-30 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$251.87 - $278.14 $6,296 - $6,953	-25 Reduced 45.45%	30 $8,000
Q3 2020 Oct 13, 2020	BUY	$167.03 - $201.3 $9,186 - $11,071	55 New	55 $10,000

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.7B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Crewe Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Crewe Advisors LLC with notifications on news.